Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 26,299 | 20,988 | 20,910 | 24,209 | 26,058 |
Cost of Goods | 6,053 | 4,912 | 5,343 | 5,951 | 5,601 |
Gross Profit | 20,246 | 16,076 | 15,567 | 18,258 | 20,457 |
Operating Expenses | 57,348 | 53,897 | 50,530 | 43,397 | 39,111 |
Operating Income | -37,049 | -36,909 | -34,620 | -24,188 | -18,053 |
Other Income | 1,018 | 1,893 | 2,894 | 3,577 | 4,103 |
Pre-tax Income | -36,031 | -35,016 | -31,726 | -20,611 | -13,950 |
Income Tax | 688 | -1,481 | -323 | N/A | N/A |
Net Income Continuous | -36,719 | -33,535 | -31,403 | -20,611 | -13,950 |
Net Income | $-36,719 | $-33,535 | $-31,403 | $-20,611 | $-13,950 |
EPS Basic Total Ops | -0.27 | -0.26 | -0.25 | 1.78 | -0.11 |
EPS Basic Continuous Ops | -0.27 | -0.26 | -0.25 | 1.73 | -0.11 |
EPS Diluted Total Ops | -0.27 | -0.26 | -0.25 | 1.78 | -0.11 |
EPS Diluted Continuous Ops | -0.27 | -0.26 | -0.25 | 1.73 | -0.11 |
EBITDA(a) | $-34,738 | $-35,006 | $-33,198 | $-23,043 | $-17,627 |